Can you use nano-hydroxyapatite toothpaste every day? Dose, safety and routine.

Yes: morning and night, as your only toothpaste, for as long as you want to use it. The reason is not that hydroxyapatite is natural or biomimetic, but that a European scientific committee has assessed the ingredient twice in documents anyone can download, each time tying its conclusion to a precisely described particle — rod-shaped, uncoated, inside a stated aspect-ratio range, and explicitly not needle-shaped¹⁷¹⁸. "Nano" on its own is not what was assessed; one particular kind of particle was, and that distinction carries the whole of the safety argument. S3 Sensitivity Science™ is formulated as a complete daily toothpaste for twice-daily use, with full adult-strength fluoride at 1450 ppm. The thing actually worth checking on a hydroxyapatite tube is not the nanoparticle: in a laboratory comparison of six desensitising toothpastes brushed on dentine to simulate six months of use, a comparison whose funding is not stated, the most abrasive of the six was the one containing zinc carbonate and hydroxyapatite, and a separate laboratory study found that particle size made no difference to abrasiveness at all⁵⁶.

What was checked16 peer-reviewed studies, two European safety opinions, UK legislation and regulator guidance, and product information as published by each brand

What has actually been assessed, and by whom?

An ingredient, twice, by a committee that publishes its reasoning — and separately a handful of laboratory studies, most of which were paid for by people who sell hydroxyapatite. Both halves of that sentence matter, and the table below keeps them apart.

The committee that wrote them, the Scientific Committee on Consumer Safety, tells the European Commission which cosmetic ingredients may be used and at what concentration. Its opinion SCCS/1648/22, adopted at the plenary meeting of 21–22 March 2023, concluded that hydroxyapatite (nano) is safe at concentrations up to 10% in toothpaste and up to 0.465% in mouthwash¹⁷. Its opinion on submission IV, SCCS/1677/25, adopted on 26 June 2025, raised those figures to 29.5% and 10% for a second, more concentrated material¹⁸. The page on why ten per cent keeps appearing sets out why the ceiling moved and why a ceiling is a limit on harm and not an instruction about benefit; what belongs here is the fencing around each conclusion, because that is the part a shopper is never shown. Why shape and size are specified before anything else is set out on the page about what nano-hydroxyapatite is.

Be exact about what those documents are. An opinion of that committee is scientific advice to the European Commission about an ingredient. It is not British law, it is not a finding that the ingredient works, and it is not an approval of any product. For a tube bought in Great Britain the primary sources are the retained Cosmetics Regulation and the regulator's own published position. Article 16 requires a cosmetic product containing nanomaterials to be notified to the Secretary of State at least six months before it is placed on the market, with the nanomaterial's identity, specification, quantity, toxicological profile and foreseeable exposure conditions²². Article 19 requires every ingredient present as a nanomaterial to be named in the ingredient list with the word "nano" in brackets, which is why the label reads as it does²³; the page on reading a hydroxyapatite label takes that apart line by line. Neither article sets a concentration limit for hydroxyapatite. The Office for Product Safety and Standards has an open call for data on nanomaterials in cosmetics, published in August 2023 and last updated that December, and hydroxyapatite (nano) is one of the materials named in it²¹. So the honest position is that the British assessment of this ingredient is still open, and this page is not going to invent a British limit to fill the gap.

Read down the funding column before you read the findings column. Four of the six research rows were paid for or written by companies that sell hydroxyapatite, and one of those companies makes the raw material that goes into S3. That is not a reason to throw the work away. It is a reason to say so in every sentence that uses it, which is what this page does.

What happens if you swallow some?

Some toothpaste always goes down, and this is the question the 2025 opinion answers most directly. The conclusion of SCCS/1677/25, adopted on 26 June 2025, states that hydroxyapatite (nano) "does not pose a mutagenic hazard or cytotoxicity or inflammatory effects even when tested at high concentrations in a buccal mucosa cell model", that "any uptake of hydroxyapatite (nano) by buccal mucosa is considered negligible, and the epithelial cells with internalised particles will be shed out over time as they are continually replaced", and that "any unintentionally ingested HAP nanoparticles during the use of oral-care products will undergo rapid dissolution in the gastric fluid and therefore do not raise any nano-specific concern over safety"¹⁸. That is the operative paragraph of a published regulatory document, and no consumer page quotes it¹⁸.

The primary work under it points the same way, with its own limits. In a laboratory study whose authors are employees of a company that makes hydroxyapatite toothpaste, one of them its president, two nano-hydroxyapatites applied at 1,000 to 50,000 ppm for 24 hours to reconstituted human oral epithelium models did not cross the stratum corneum at all, and in the model that lacked one they reached the outermost layer of cells and went no deeper¹. The dose was set deliberately above what brushing would deliver, and the models have no saliva, no mucin and none of the barrier behaviour of a real mouth, which the paper says itself. For the swallowing half of the question, a 2018 review of the health risks of nanoscopic calcium phosphate concluded that there is no risk from oral uptake because the particles dissolve rapidly in the stomach, that the risk from dermal or mucosal uptake is very low, and that the cytotoxicity reported in some cell-culture work is probably an artefact of particles clumping and settling onto the cell layer at a very high local concentration².

Both papers, whose authors are affiliated with the maker of the material tested, report that a commercial oral-care nano-hydroxyapatite is cytocompatible under the ISO cytotoxicity standard, produces no genotoxicity in the micronucleus assay, and leaves internalised particles in the cytoplasm and the extracellular space rather than in the nucleus³⁴. The company concerned is Fluidinova, which makes the nanoXIM raw material; the nano-hydroxyapatite in S3 is nanoXIM CarePaste, tested to the committee's guidance for nanomaterials, and the committee has separately published an opinion on hydroxyapatite (nano) in oral products. Tested to a guidance is not the same thing as assessed as a product, and no toothpaste on any shelf has been assessed by that committee.

None of this is a benefit to a person. It is a set of laboratory and regulatory findings about an ingredient, and the strongest thing they support is the absence of a nano-specific reason to worry — not a reason to brush more.

Do the trials record any harm from daily use?

Mostly they do not say, and that is worth knowing.

The eight-week randomised double-blind trial that tested nano-hydroxyapatite toothpastes at ten and fifteen per cent, sponsored by the maker of the test pastes, screened every participant for adverse events at each two-weekly visit by questioning and by examining the mouth and the surrounding skin, and recorded that no adverse event or compromised oral health was reported or found at any point⁹. That is the only trial on this page that states how it looked. The four-week randomised trial in 105 adults does not report adverse-event collection in its abstract¹⁰. Neither does the two-year children's trial¹¹. A PubMed search on hydroxyapatite dentifrices and adverse events, safety or tolerability, run for this page in September 2026, returned eleven records, and none of them was a randomised comparison in people that says whether it looked. So the accurate statement is that most of the literature on this ingredient does not tell you whether anybody was asked, and a page that says otherwise is filling a silence.

The one piece of work built around daily use rather than around symptoms makes the point in a different way. A 12-week prospective randomised double-blind two-centre trial, funded by the maker of the paste it tested, gave 70 adults with periodontitis either a microcrystalline zinc hydroxyapatite dentifrice or an amine-fluoride and stannous-fluoride dentifrice to use as their normal oral care, with no hygiene instruction⁸. In that manufacturer-funded trial the primary outcome, the rate at which plaque re-formed, did not change significantly in either group, and none of the secondary clinical or microbiological differences between the groups reached significance either⁸. Twelve weeks of unsupervised daily use, paid for by a company with an advantage to find, found none.

Length of exposure is the other half of "every day". The pooled evidence for this ingredient in sensitivity runs to four weeks of twice-daily use and no further: a 2019 systematic review and meta-analysis of six randomised trials rated its pooled effect as high-quality evidence and its authors called for long-term randomised trials before definitive recommendations¹⁵. Nothing longer than that two-year triple-blind study in children has turned up, either in this library or in the searches run for this page¹¹. For adults the record is a six-month randomised trial in 150 orthodontic patients, funded by the maker of the paste tested¹². A PubMed search for randomised evidence covering a year or more of hydroxyapatite toothpaste in adults, run for this page in September 2026, returned nothing at all. That is the honest boundary of "for as long as you want to use it": what has been measured is weeks to months, and the reassurance beyond that rests on what the ingredient is, not on anything anybody has yet measured.

Can S3 be your only toothpaste?

Yes — that is what the formula is for, not a concession inside it.

S3 is not a fortnight's treatment you stop when the twinge fades, which is what a single-active desensitising paste tends to be. It is SLS-free and vegan, and it is built to be used morning and night as a whole toothpaste instead of a short course. The fluoride is the load-bearing part of that sentence: S3 keeps full adult-strength fluoride at 1450 ppm as sodium monofluorophosphate, so unlike fluoride-free hydroxyapatite pastes it does not ask you to give up decay protection.

That matters because the independent evidence on hydroxyapatite as a fluoride substitute is not settled. Pooling four randomised trials in people under 25, a 2025 systematic review and meta-analysis put the caries risk ratio between a fluoride-free hydroxyapatite paste and a fluoride one at 0.98, with a confidence interval running from 0.85 to 1.12¹³. Statistically indistinguishable is not the same as equivalent: on four small studies it means nothing was detected, which is a weaker thing. A 2022 systematic review of ten clinical and in situ studies could pool nothing from the clinical arm, rated its certainty very low, and noted that six of the ten studies were funded or published by the makers of the products tested¹⁴. Whether a hydroxyapatite paste can replace fluoride is argued properly on the page about what happens to softened enamel and on the page about the toothpastes that drop fluoride altogether. What matters here is only that S3 does not make you choose.

The routine below is the pack's, with each instruction traced to whoever actually says it. Where nothing says it, the row says so. S3's declared levels — nano-hydroxyapatite at 10% and biomimetic hydroxyapatite at 5% — are inclusion levels of the ingredient as supplied rather than the weight of mineral in the finished paste, and the active content is lower.

The Oral Health Foundation's sensitive-teeth page does suggest rubbing a little sensitive toothpaste onto the painful area at night, and it is worth saying why the row above is empty. That instruction is not the instruction on this pack, S3 is a rinse-off toothpaste used in place of your usual one, and usage instructions come from the pack. The same page names potassium citrate, potassium nitrate and stannous fluoride as the actives to look for and does not mention hydroxyapatite at all¹⁹; it also carries an educational grant from a toothbrush manufacturer, which its own footer states. The Journal's guide to how to stop sensitive teeth pain covers the short-term decisions that sit alongside the daily routine.

Is a hydroxyapatite toothpaste abrasive?

Some are. Abrasivity is a property of the whole formulation, not of hydroxyapatite, which is exactly why "nano" is the wrong word to be reading on the tube.

The uncomfortable finding first. In a laboratory model whose funding is not stated, dentine discs cut from 70 extracted human molars were brushed with six commercially available desensitising toothpastes to simulate six months of use, and the height lost was measured by profilometry against a tap-water control⁵. Every paste but one abraded significantly more dentine than water, the greatest abrasion of the six was measured for the paste containing zinc carbonate and hydroxyapatite, and the least for the paste built on pro-arginine and calcium carbonate, in work with no funding statement on the record⁵. That is a hydroxyapatite-containing product at the top of the abrasion range, printed here because it is true and because a page that hides the unflattering findings is not worth reading.

Now the part that keeps it in proportion. In a separate laboratory erosion-and-abrasion model on human enamel, covering sixteen toothpastes including three hydroxyapatite ones, brushing increased tissue loss in almost every product tested; the relationship between abrasiveness and the quantity of particles in a formulation was non-linear, and particle size had no impact on abrasiveness at all⁶. An independent 2025 analysis of marketed hydroxyapatite oral-care products measured relative enamel and relative dentine abrasivity directly and found neither associated with the tissue loss it recorded, and found the particulate fraction of every toothpaste examined dominated by silicon and oxygen rather than by calcium and phosphorus⁷. Put together: what scrapes is the abrasive system a formulator builds — usually silica — not the size of the mineral particle, and a scoping review of 368 formulations across 138 randomised trials of desensitising toothpaste confirms that silica-based abrasives are commoner in this literature than calcium-based ones¹⁶. The erosion side of that evidence is argued in full on the remineralisation page and is not re-argued here.

So the useful thing to look for on a tube is a relative dentine abrasivity figure, and here is the problem with that advice: almost nobody publishes one. Of the sensitivity toothpastes recorded in our own scan of the UK shelf in September 2026, exactly one product page states a relative dentine abrasivity value, and that product carries no desensitising active at all; not one of the hydroxyapatite toothpastes in the scan states one. Neither does S3. There is an unconfirmed figure in our own notes and this page will not print it, because a number we cannot stand behind is worse than an admission. The category review lists what every one of those products does declare.

Is it safe for children?

The evidence for children is about duration and dentition, not about safety, and the two are easy to confuse.

The largest and longest trial in this literature enrolled 610 children in a triple-blind randomised design and had them brush three times a day for two years with toothpastes combining substituted hydroxyapatite and fluoride, against sodium monofluorophosphate toothpastes at matched fluoride levels; by 24 months the hydroxyapatite-fluoride group had fewer active enamel lesions, and 518 children completed¹¹. What that trial demonstrates about safety is indirect: several hundred small children used these toothpastes three times daily for two years inside a monitored study¹¹. It was not designed to measure harm, its outcome was caries activity, and the pastes it tested carried fluoride rather than replacing it.

A PubMed search for paediatric safety, ingestion or swallowing data on hydroxyapatite toothpaste, run for this page in September 2026, returned three records, and not one of them looked at children swallowing it. So there is no paediatric ingestion study to cite, and the general finding about the ingredient class — rapid dissolution in the stomach, no risk from oral uptake — comes from a review of calcium phosphate rather than from work in children². How much fluoride a child's toothpaste should carry, and at what age, is a separate question with its own guidance and its own page on fluoride, hydroxyapatite and children; it is not answered here, and a hydroxyapatite ingredient list does not change the answer.

When should you stop brushing and see a dentist?

When the pain stops behaving like sensitivity, a toothpaste is the wrong tool and waiting is the wrong plan.

Four patterns are worth watching for, and the Oral Health Foundation lists them: pain that is severe, sensitivity that has run on for more than a few weeks, a single affected tooth rather than a region, and pain that begins out of nowhere. Any of the four can turn out to be decay, a crack, gum problems or infection¹⁹. The NHS sets its own threshold for toothache: see a dentist if it lasts more than two days, if painkillers do not settle it, or if it arrives with a high temperature, pain on biting, red gums or a bad taste, and go to A&E if there is swelling around the eye or neck or difficulty breathing, swallowing or speaking²⁰. Sudden pain, or pain in one tooth, means an appointment, not a different tube. Fluoride works against decay and hydroxyapatite can fill microlesions, but neither of those is what a cracked tooth or an abscess needs.

None of that is a reason to stop using a daily toothpaste while you wait. It is a reason not to let a toothpaste stand in for a diagnosis.

Frequently asked questions

Is S3 too abrasive to use twice a day?

We cannot answer that with a number, and the honest version is more useful than a reassuring one. S3 publishes no relative dentine abrasivity figure, and this page will not estimate one. What the published work shows is that abrasivity belongs to the whole formulation rather than to hydroxyapatite: in the six-toothpaste laboratory comparison whose funding is not stated, a paste containing zinc carbonate and hydroxyapatite abraded the most dentine and a stannous fluoride paste was the only one that did not differ from water⁵, while a separate laboratory model found particle size had no effect on abrasiveness⁶. If you want a number before you buy, ask any brand for its relative dentine abrasivity value, including ours.

Is nano-hydroxyapatite safe to swallow?

The regulatory answer is that accidentally swallowing some while brushing raises no nano-specific safety concern, because the particles dissolve rapidly in the gastric fluid — that is the conclusion of opinion SCCS/1677/25, adopted on 26 June 2025¹⁸. The independent literature agrees on the mechanism: a 2018 review of nanoscopic calcium phosphate found no risk from oral uptake for the same reason². Neither statement is about eating toothpaste, and neither is a reason to swallow it on purpose.

Do you need to stop after a few weeks?

No, and stopping is how the effect is lost. The Oral Health Foundation's position is that sensitive toothpastes work by blocking the tiny channels in dentine and that you need to keep using them to maintain the effect¹⁹. Every trial cited on this page ran continuous daily use for its whole length, from four weeks to two years¹⁰¹¹. S3 is built for that: the daily toothpaste rather than the fortnight's course.

Does using it every day make it work better?

Daily use is the condition under which the ingredient was tested, which is not the same as more being better. The pooled sensitivity evidence covers four weeks of twice-daily brushing and its authors asked for longer trials before firm recommendations¹⁵, and no trial found in the searches run for this page set three times a day against twice a day in adults. Brushing harder or longer is not a way to speed anything up, and the abrasion evidence above is a reason not to try. The page on how long it takes to work sets out what those early weeks look like, and the page on what percentage a paste needs covers the dose question underneath it.